These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
8. Closing in on a melanoma skin cancer vaccine. Mayo Clin Health Lett; 2012 Oct; 30(10):4. PubMed ID: 23133855 [No Abstract] [Full Text] [Related]
9. Melanoma vaccines: achievements and perspectives. Brichard VG; Gérard C Forum (Genova); 2003; 13(2):144-54; quiz 189. PubMed ID: 14732881 [TBL] [Abstract][Full Text] [Related]
10. Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine. Sondak VK; Sosman JA Semin Cancer Biol; 2003 Dec; 13(6):409-15. PubMed ID: 15001159 [TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy for melanoma: how can tolerance be overcome?]. Robert C Ann Dermatol Venereol; 2001; 128(6-7):709-13. PubMed ID: 11460031 [No Abstract] [Full Text] [Related]
12. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine. Hsueh EC; Morton DL Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic and autologous melanoma vaccines: where have we been and where are we going? Sondak VK; Sabel MS; Mulé JJ Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2337s-2341s. PubMed ID: 16609055 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma. Gordon LK; Ribas A; Nusinowitz S; Butterfield LH; Glaspy JA; Economou JS; Straatsma BR Control Clin Trials; 2004 Aug; 25(4):400-7. PubMed ID: 15296814 [TBL] [Abstract][Full Text] [Related]
18. [Active specific immunotherapy of malignant melanoma]. Lotem M; Shiloni E; Ingber A; Peretz T Harefuah; 1997 Aug; 133(3-4):122-6. PubMed ID: 9332080 [No Abstract] [Full Text] [Related]